STATE STREET CORP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$64,328,457
+1.9%
3,139,505
-1.2%
0.00%
+33.3%
Q2 2023$63,157,272
-8.3%
3,178,524
-20.9%
0.00%
-25.0%
Q1 2023$68,857,221
-55.8%
4,019,686
-49.5%
0.00%
-20.0%
Q4 2022$155,737,472
+187.6%
7,957,970
+134.6%
0.01%
+66.7%
Q3 2022$54,142,000
+55.1%
3,392,333
+33.8%
0.00%
+50.0%
Q2 2022$34,899,000
-20.1%
2,536,257
-7.9%
0.00%0.0%
Q1 2022$43,673,000
-14.6%
2,753,647
+17.5%
0.00%0.0%
Q4 2021$51,157,000
-26.9%
2,343,413
+0.1%
0.00%
-50.0%
Q3 2021$69,941,000
-10.3%
2,339,934
+32.9%
0.00%0.0%
Q2 2021$77,990,000
+9.0%
1,760,900
+9.2%
0.00%0.0%
Q1 2021$71,573,000
+12.9%
1,613,088
+39.5%
0.00%0.0%
Q4 2020$63,398,000
+69.8%
1,156,045
-29.2%
0.00%
+33.3%
Q3 2020$37,332,000
+12.3%
1,633,055
+2.8%
0.00%
+50.0%
Q2 2020$33,245,000
+146.8%
1,588,389
+64.5%
0.00%
+100.0%
Q1 2020$13,472,000
-34.9%
965,715
+6.2%
0.00%0.0%
Q4 2019$20,702,000
+81.9%
909,562
-6.9%
0.00%0.0%
Q3 2019$11,381,000
-30.2%
976,873
-10.1%
0.00%0.0%
Q2 2019$16,303,000
+9.0%
1,086,872
+27.5%
0.00%0.0%
Q1 2019$14,954,000
+164.3%
852,573
+123.3%
0.00%0.0%
Q4 2018$5,659,000
-38.3%
381,842
+2.4%
0.00%0.0%
Q3 2018$9,173,000
+29.8%
372,734
+3.6%
0.00%0.0%
Q2 2018$7,065,000359,8920.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders